Trial Profile
Group study of UFT following instillation of anticancer drug for superficial bladder cancer
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Acronyms GUARD
- 17 May 2011 New trial record